Private Equity

Research

Dashboard: Fundraising drops, IPOs spike in May

M&A takes a big hit in May, with only deal with disclosed financials

2 min read · 09 June 2016

Unicorn valuations can be triple fair market value: Stanford study

VC-backed unicorns boast of billion-dollar valuations, but these eye-popping numbers can be as much as 200 percent above fair market value, says a Stanford Prof

2 min read · 31 May 2016

Venture investing shifts away from traditional Silicon Valley

When the phrase Silicon Valley came into being in the early 1970s, it referred to a group of Santa Clara Valley communities south of San Francisco with the city of San Jose as its hub. Turns out this birthplace of the modern high-tech industry is losing some of its mojo, at least for venture capitalists.

3 min read · 03 May 2016

Dashboard: Fundraising keeps climbing in March

M&A also takes a leap forward in March, thanks to a large acquisition of a VC-backed company by Cisco

2 min read · 12 April 2016

Venture slump overstated as growth-round deal-making rises

The new year started off with less hesitation than many in venture feared during the turbulent three months

1 min read · 04 April 2016

Corporate buyers playing a big role in exit markets

Exit markets are felt the pinch, but corporate acquisitions have continued to display remarkable strength.

2 min read · 18 March 2016

Dashboard: Fundraising soars in February

IPOs come back from the dead, thanks to four VC-backed biotech companies debuting

2 min read · 16 March 2016

Venture-backed stocks hold steady in February

The venture-backed stock index falls again, but only by 2.89 points and could be rebounding back up

2 min read · 01 March 2016

Bucking the trend, round sizes in venture deals climb

The good times may be over for late-stage companies, which have seen their valuations drop, but round sizes for VC deals aren’t not even close to shrinking

2 min read · 24 February 2016

Dashboard: VC-backed M&A heats up in December; IPOs remain cold

M&A proceeds spiked in December thanks to Bristol-Myers' $2.1 billion acquisition of Cardioxyl, the largest acquisition of a venture-backed company in 2015

2 min read · 13 January 2016

Showing 21 to 30 of 56 results